enVVeno Medical Corp 8-K

What Happened
enVVeno Medical Corporation (NVNO) announced a one-for-thirty-five (1:35) reverse stock split of its common stock, effective 12:01 a.m. Eastern Time on January 20, 2026. The Company filed a Certificate of Amendment with the Delaware Secretary of State after approval by its board and stockholders. The Common Stock began trading on a split-adjusted basis that same day.

Key Details

• Outstanding shares were reduced from 22,946,223 to 655,606 following the reverse split.
• Par value per share remained $0.00001; authorized shares remain 250,000,000.
• No fractional shares were issued; any fractional interests were rounded up to the nearest whole share.
• Outstanding options and warrants were adjusted proportionally (shares reduced by 35x; exercise prices increased by 35x). Example: a warrant for 3,500 shares at $0.30 became 100 shares at $10.50.
• Equiniti Trust Company, LLC is acting as exchange agent; brokerage-held positions will be adjusted automatically.

Why It Matters
A reverse split reduces the number of outstanding shares and typically raises the per‑share price proportionally, which can affect liquidity, market perception, and certain listing or regulatory metrics. The proportional adjustments to options and warrants preserve their economic exposure, while rounding up fractional shares slightly increases the post-split share count. Investors holding NVNO through brokers do not need to take action—their positions will be updated automatically.